ABSTRACT
INTRODUCTION: The objective of this study was to investigate myocardial deformation of left (LV) and right ventricle (RV) using 2-dimensional speckle-tracking echocardiography (2D-STE) in fetuses with and without congenital cytomegalovirus (CMV) infection. METHODS: This was a prospective single-center study. Vertical transmission was defined by a positive CMV polymerase chain reaction (PCR) test on the amniotic fluid or on the neonate's urine. Fetuses were divided into group 1 and group 2 if CMV-PCR was positive or negative, respectively. LV and RV global longitudinal strain (GLS) values were obtained and adjusted for gestational age by calculating Z-scores. Univariate analysis was carried out to compare cardiac indices between group 1 and group 2. RESULTS: Fetuses from group 1 (n = 11) had a significantly lower LV myocardial shortening than those from group 2 (n = 32). GLS was -20.7 ± 5.2% and -26.3 ± 4.1%, respectively (p = 0.001). Similarly, GLS Z-score was lower (0.02 ± 0.72) in group 1 than in group 2 (-0.80 ± 0.59) (p = 0.001). Similarly, RV GLS Z-score was significantly impaired in group 1 compared to group 2 (-0.44 ± 1.03 vs. -1.04 ± 0.71, p = 0.041). CONCLUSION: Fetuses with congenital CMV showed subclinical biventricular myocardial dysfunction. Further studies are needed to confirm the potential role of 2D-STE in identifying fetuses with congenital CMV at risk of postnatal cardiovascular morbidities.
Subject(s)
Cytomegalovirus Infections , Echocardiography , Infant, Newborn , Humans , Prospective Studies , Echocardiography/methods , Fetal Heart/diagnostic imaging , Cytomegalovirus Infections/diagnostic imaging , Heart Ventricles/diagnostic imagingABSTRACT
INTRODUCTION: Fetal growth restriction (FGR) affects 5%-10% of all pregnancies, contributing to 30%-50% of stillbirths. Unfortunately, growth restriction often is not detected antenatally. The last weeks of pregnancy are critical for preventing stillbirth among babies with FGR because there is a pronounced increase in stillbirths among growth-restricted fetuses after 37 weeks of pregnancy. Here we present a protocol (V.1, 23 May 2016) for the RATIO37 trial, which evaluates an integrated strategy for accurately selecting at-risk fetuses for delivery at term. The protocol is based on the combination of fetal biometry and cerebroplacental ratio (CPR). The primary objective is to reduce stillbirth rates. The secondary aims are to detect low birth weights and adverse perinatal outcomes. METHODS AND ANALYSIS: The study is designed as multicentre (Spain, Chile, Mexico,Czech Republic and Israel), open-label, randomised trial with parallel groups. Singleton pregnancies will be invited to participate after routine second-trimester ultrasound scan (19+0-22+6 weeks of gestation), and participants will be randomly allocated to receive revealed or concealed CPR evaluation. Then, a routine ultrasound and Doppler scan will be performed at 36+0-37+6 weeks. Sociodemographic and clinical data will be collected at enrolment. Ultrasound and Doppler variables will be recorded at 36+0-37+6 weeks of pregnancy. Perinatal outcomes will be recorded after delivery. Univariate (with estimated effect size and its 95% CI) and multivariate (mixed-effects logistic regression) comparisons between groups will be performed. ETHICS AND DISSEMINATION: The study will be conducted in accordance with the principles of Good Clinical Practice. This study was accepted by the Clinical Research Ethics Committee of Hospital Clinic Barcelona on 23May 2016. Subsequent approval by individual ethical committees and competent authorities was granted. The study results will be published in peer-reviewed journals and disseminated at international conferences. TRIAL REGISTRATION NUMBER: NCT02907242; pre-results.
Subject(s)
Fetal Growth Retardation/diagnostic imaging , Fetal Monitoring , Placental Insufficiency/diagnostic imaging , Pregnancy Complications/diagnostic imaging , Pregnancy Trimester, Third , Stillbirth/epidemiology , Adult , Chile , Czech Republic , Female , Fetal Growth Retardation/mortality , Fetal Growth Retardation/physiopathology , Humans , Infant, Newborn , Israel , Mexico , Placental Insufficiency/mortality , Placental Insufficiency/physiopathology , Pregnancy , Pregnancy Complications/physiopathology , Pregnancy Outcome , Prenatal Care/statistics & numerical data , Spain , Ultrasonography, Prenatal/statistics & numerical data , Young AdultABSTRACT
Our technical ability to diagnose fetal anomalies of the central nervous system by ultrasonography and by fetal magnetic resonance imaging far exceeds our current knowledge of their possible neurodevelopmental implications later in life. This limitation often makes obstetric and clinical decisions very difficult. We retrospectively reviewed the ultrasonographic records of 6220 women who had been followed up at two large medical centers between 1994 and 1999. One hundred and sixty (2.6%) women had abnormal fetal central nervous system findings. The neurodevelopmental outcome of these children was assessed by a telephone interview with the parents. Small cerebellar size was the most frequent anomaly, followed by isolated mild ventriculomegaly and isolated choroid plexus pathology. Suboptimal neurodevelopmental outcome was found in 24% of children with isolated ventriculomegaly and in 9% with choroid plexus pathology. In the group of children with a "small cerebellum," suboptimal neurodevelopment was found in 19%. The measurement of transcerebellar diameter in respect to its developmental implication is, to our knowledge, described here for the first time. We believe that cerebellar measurements and their possible neurocognitive implications should be an integral part of future studies.
Subject(s)
Brain/abnormalities , Cerebellum/abnormalities , Cerebellum/diagnostic imaging , Child Development , Choroid Plexus/abnormalities , Choroid Plexus/diagnostic imaging , Ultrasonography, Prenatal , Abortion, Induced , Adult , Brain/growth & development , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Pregnancy , Prognosis , Retrospective StudiesABSTRACT
OBJECTIVE: To evaluate the effect of long-term (1-week) oral hydration on amniotic fluid volume in women with an amniotic fluid index (AFI) < 10th percentile. STUDY DESIGN: This prospective, nonrandomized, interventional study was conducted on 30 women with AFI < 10th percentile. Study inclusion criteria were singleton pregnancy, well-established gestational age, intact membranes, no maternal complications (e.g., hypertension, cardiovascular disease, hyperthyroidism), no evidence of preeclampsia, no fetal structural malformations and no evidence of fetal distress. The women were instructed to drink at least 2L of water daily; their AFI was evaluated before and 1 week after the initiation of oral hydration. The study group was compared to a control group of 30 women matched for age and gestational age, with AFI > 10th and < 90th percentile. RESULTS: AFI increased from 8.1 +/- 0.73 (mean +/- SD) to 11.8 +/- 2.4 1 week later (P < .01) in 25 (83%) of the study subjects. The AFI was similar before and 1 week after oral hydration in all the controls. CONCLUSION: Long-term maternal oral hydration seems to significantly increase the AFI in selected women with reduced fluid and possibly prevents oligohydramnios.
Subject(s)
Amniotic Fluid , Fluid Therapy , Oligohydramnios/prevention & control , Adult , Female , Follow-Up Studies , Gestational Age , Humans , Oligohydramnios/diagnostic imaging , Pregnancy , Pregnancy Outcome , Prospective Studies , Time Factors , Ultrasonography, PrenatalABSTRACT
Retained products of conception (RPOC) present a major clinical challenge. We assessed the accuracy of an evaluation protocol based on clinical management and transvaginal ultrasonographic evaluation for the detection of retained products of conception. This combined clinical and sonographic evaluation protocol offers a high sensitivity for the accurate diagnosis of RPOC.
Subject(s)
Fertilization , Placenta, Retained/diagnostic imaging , Placenta, Retained/pathology , Contrast Media , Female , Humans , Placenta, Retained/surgery , Pregnancy , Retrospective Studies , Sensitivity and Specificity , Ultrasonography, Doppler/methodsABSTRACT
Women who have retained products of conception are usually referred for curettage or hysteroscopy, both performed in most cases under general anesthesia in an operating theater and sometimes requiring hospitalization. We propose that for most of these patients the procedure can be just as safely and effectively carried out in an obstetric ultrasound unit.
Subject(s)
Placenta, Retained/diagnostic imaging , Placenta, Retained/therapy , Surgical Instruments , Ultrasonography, Doppler, Color/methods , Dilatation and Curettage , Female , Humans , Hysteroscopy , Oxytocics/pharmacology , Postpartum Hemorrhage/etiology , Postpartum Hemorrhage/therapy , Pregnancy , Retrospective Studies , Uterine Contraction/drug effectsABSTRACT
OBJECTIVE: To generate nomograms for the sonographic measurement of the fetal philtrum and chin during pregnancy. DESIGN: A prospective, cross-sectional study in normal singleton pregnancies. SUBJECTS: One hundred and fifty-three fetuses between 13 and 42 weeks of gestation were studied. METHODS: The philtrum was measured from the base of the columella to the upper lip. The chin was measured from the tip of the lower lip to the skin under the lower tip of the mandible. Predictive models were evaluated to generate graphic description of the 5th, 50th and 95th centiles for the fetal philtrum and chin. RESULTS: Fetal philtrum length increased with gestational age. The regression equation for the philtrum length (y) according to gestational age in weeks (x) is best predicted by the S-curve (Gompertz) model, as described by the following equation: y = exp(a + b/x), where a = 2.778577, and b = -23.476723 (R(2) = 85.3%, p < 0.0001). The fetal chin length increased with gestational age. The regression equation for the mean chin length (y) according to gestational age in weeks (x) is best predicted by the S-curve model as described in the following equation. y = exp(a + b/x), where a = 3.7922, b = -28.043, (R(2) = 89.0%, p < 0.0001). CONCLUSIONS: The nomograms generated in this study for the fetal philtrum and chin during pregnancy can be used in confirming subjective impression of facial dysmorphism.
Subject(s)
Chin/embryology , Lip/embryology , Nomograms , Ultrasonography, Prenatal , Chin/diagnostic imaging , Female , Gestational Age , Humans , Lip/diagnostic imaging , Micrognathism/diagnostic imaging , Pregnancy , Regression AnalysisABSTRACT
PURPOSE: To evaluate the application of transvaginal sonography assessment of cervical length before fetal reduction for predicting spontaneous preterm birth in triplet gestations reduced to twins. METHODS: This retrospective study was conducted at the ultrasound unit of a university-affiliated municipal hospital. The study cohort consisted of 25 women with triplet gestations following ovulation induction or assisted-reproduction techniques who underwent fetal reduction to twins. Cervical length was assessed via transvaginal sonography before fetal reduction, and data on pregnancy outcome were retrieved from maternal records and/or maternal interviews. RESULTS: Cervical length (mean +/- SD) at reduction was 4.0 +/- 0.85 (range: 1.2-5.5). Five women were excluded from statistical evaluation because pregnancy complications precluded spontaneous delivery. Two of 3 (67%) women with a cervical length of <3.5 cm delivered prior to 33 weeks' gestation compared with 1/17 (6%) women with a cervical length > or = 3.5 cm. This difference was statistically significant (P < 0.05). The sensitivity, specificity, positive predictive value, and negative predictive value of cervical lengths <3.5 cm to predict delivery prior to 33 gestational weeks was 67%, 94%, 67%, and 94%, respectively. CONCLUSIONS: Measurement of cervical length in triplet pregnancies before fetal reduction provides useful predictive information on the risk for preterm delivery.
Subject(s)
Cervix Uteri/diagnostic imaging , Obstetric Labor, Premature/diagnostic imaging , Pregnancy Reduction, Multifetal , Ultrasonography, Prenatal , Adult , Cervix Uteri/anatomy & histology , Female , Humans , Predictive Value of Tests , Pregnancy , Pregnancy Outcome , Pregnancy, Multiple , Premature Birth , Retrospective Studies , Sensitivity and Specificity , TripletsABSTRACT
OBJECTIVE: To assess the feasibility of nuchal translucency in triplets compared with singletons. METHODS: Nuchal translucency thickness as part of routine first-trimester screening in the general population was compared between 3128 singleton pregnancies and 51 triplets (153 fetuses). Crown-rump length was also noted. The 5th, 50th, and 95th percentiles were determined and compared between the 2 groups, and regression curves of nuchal translucency measurements plotted against crown-rump length were drawn. RESULTS: The mean nuchal translucency thickness was 1.23 mm for singletons and triplets. The 5th and 95th percentiles were also the same between the 2 studied groups. The regression curves of 5th, 50th, and 95th percentiles of nuchal translucency plotted against crown-rump length of triplets and singletons overlapped. CONCLUSIONS: Nuchal translucency values and distribution are the same in triplets and singletons, validating the utility of the cutoff values.
Subject(s)
Neck/diagnostic imaging , Triplets , Ultrasonography, Prenatal , Adult , Crown-Rump Length , Feasibility Studies , Female , Humans , Neck/embryology , PregnancyABSTRACT
BACKGROUND: Maternal serum HCG (MSHCG) is higher when the fetus is a female than when it is male. This has been demonstrated in the second and third trimesters of pregnancy, and recently at 10-14 weeks gestation. In this study we assessed whether this gender-related difference can be detected as early as week 3 post-fertilization. METHODS: The IVF setting was chosen because it provides precise dating of gestational age and early sonography for the number of gestational sacs. The study included 347 IVF cycles from 335 patients. Only pregnancies with a single implanted embryo that resulted in a single live birth of known gender were included. MSHCG was measured on days 14-20 post-fertilization, and levels were expressed as gestational age-corrected multiples of the median (MoMs). The log10 MSHCG MoMs were compared according to fetal gender. RESULTS: MSHCG levels were significantly higher (18.5%) in week 3 post-fertilization in the presence of a female fetus (P < 0.0002). CONCLUSION: Because a fetal gender-related difference in MSHCG can be demonstrated as early as week 3 post-fertilization, the difference may be attributed to placental factors and not to the effects of the fetal hypothalamic-hypophyseal-gonadal axis.
Subject(s)
Chorionic Gonadotropin/blood , Fetus/physiology , Gestational Age , Pregnancy/blood , Sex Characteristics , Female , Humans , MaleABSTRACT
OBJECTIVE: To assess the sonographic detection rate of fetal undescended testes among a low-risk population during the third trimester. METHODS: A sonographic evaluation, which included biometric studies and a detailed examination of the fetal genitalia, was performed prospectively on 332 male fetuses of singleton pregnancies between 34 and 40 weeks' gestation. A qualified neonatologist examined the presence of the testes within the scrotum within 3 days after birth. RESULTS: The scrotum was visible in 294 (89%) of the 332 fetuses who were examined. It was visible in all fetuses evaluated between 34 and 36 weeks' gestation. Nine cases of undescended testes were detected (3%). Of these, the diagnosis of 1 case, examined at 34 weeks' gestation, was revealed after birth to be false-positive. There were no false-negative results. CONCLUSIONS: Sonographic examination during the late third trimester of pregnancy appears to allow accurate diagnosis of undescended testes prenatally. This early identification will alert the neonatologist of the possibility of cryptorchidism and will permit early postnatal identification and treatment.